Stock comparison
BECTON DICKINSON & CO is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($41.87 B vs $2.35 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BDX is larger
BECTON DICKINSON & CO is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($41.87 B vs $2.35 B).
Market value leader
BDX
BECTON DICKINSON & CO is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($41.87 B vs $2.35 B).
Revenue leader
BDX
LMAT: $249.60M vs BDX: $21.84B.
Profit leader
BDX
LMAT: $57.70M vs BDX: $1.68B.
Margin leader
LMAT
LMAT: 23.1% vs BDX: 7.7% net margin.
| Metric | LMAT | BDX |
|---|---|---|
| Market cap | $2.35 B | $41.87 B |
| US-listed rank | #2018 | #371 |
| Revenue (latest FY) | $249.60M | $21.84B |
| Net income (latest FY) | $57.70M | $1.68B |
| Net margin | 23.1% | 7.7% |
| P/E (trailing FY) | 40.7x | 24.9x |
| SEC filings | 1,849 | 3,027 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BECTON DICKINSON & CO is 17.8x more valuable than LEMAITRE VASCULAR INC by market capitalization ($41.87 B vs $2.35 B).
In their latest fiscal years, LEMAITRE VASCULAR INC reported $249.60M in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: LEMAITRE VASCULAR INC and BECTON DICKINSON & CO, or browse the full rankings.